Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Terns Pharmaceuticals, Inc. (TERN) had Free Cash Flow per Share of $-0.88 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-88.85M |
|
-- |
|
-- |
|
$101.87M |
|
$-101.87M |
|
$13.28M |
|
$-88.59M |
|
$-88.59M |
|
$-88.85M |
|
$-88.85M |
|
$-88.85M |
|
$-88.85M |
|
$-101.87M |
|
$-100.97M |
|
79.51M |
|
79.51M |
|
$-1.12 |
|
$-1.12 |
|
| Balance Sheet Financials | |
$362.11M |
|
$0.22M |
|
$1.82M |
|
$363.93M |
|
$15.65M |
|
-- |
|
$2.41M |
|
$18.06M |
|
$345.87M |
|
$345.87M |
|
$345.87M |
|
87.13M |
|
| Cash Flow Statement Financials | |
$-70.02M |
|
$-12.41M |
|
$164.00M |
|
$79.93M |
|
$161.44M |
|
$81.51M |
|
$15.63M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
23.14 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-70.06M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-25.69% |
|
-25.69% |
|
-24.41% |
|
-25.69% |
|
$3.97 |
|
|
Free Cash Flow per Share |
$-0.88 |
$-0.88 |
|